PRECOMB THERAPEUTICS
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
PRECOMB THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2018-01-01
Address:
Hombrechtikon, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.precomb.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.5 M CHF
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress LetsEncrypt Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin Apache
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Remasters
Remasters develops technology to synthesize new restriction enzymes.
Current Advisors List
Current Employees Featured
Founder
Investors List
LongeVC
LongeVC investment in Seed Round - PreComb Therapeutics
Kinled Holding
Kinled Holding investment in Seed Round - PreComb Therapeutics
Kinled Holding
Kinled Holding investment in Seed Round - PreComb Therapeutics
FiveT Capital AG
FiveT Capital AG investment in Seed Round - PreComb Therapeutics
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - PreComb Therapeutics
Official Site Inspections
http://www.precomb.com Semrush global rank: 10.32 M Semrush visits lastest month: 234
- Host name: sl80.web.hostpoint.ch
- IP address: 217.26.53.186
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "PreComb Therapeutics"
PreComb Company Profile 2024: Valuation, Funding
PreComb General Information Description. Developer of a 3D drug testing technology designed for vitro cancer diagnosis to improve cancer …See details»
PreComb Therapeutics - Crunchbase Company Profile …
Organization. PreComb Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
PreComb - LinkedIn
PreComb | 973 followers on LinkedIn. AI-guided Functional Precision Medicine | PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer …See details»
PreComb Therapeutics AG - Swiss Biotech
PreComb Therapeutics AG develops a new 3D drug testing platform for cancer patients. The automated profiling device will allow pharma R&D and clinicians to perform personalized profiling of cancer drugs and drug combinations directly …See details»
PreComb - Company Profile - Tracxn
Dec 5, 2024 PreComb. has raised a total funding of $3.72M over 2 rounds. Its first funding round was on Apr 26, 2021. What are the most recent funding rounds of PreComb? Its latest funding …See details»
PreComb Therapeutics - VentureRadar
PreComb Therapeutics AG is a privately held Swiss biotech company developing proprietary technology to enable evidence-based treatment decisions in cancer. The 3DTwin technology …See details»
PreComb - Overview, News & Similar companies | ZoomInfo.com
Apr 27, 2021 View PreComb (www.precomb.com) location in Zurich, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
About - PreComb - Functional cancer profiling
PreComb is a privately held Swiss biotech company developing proprietary technologies to enable evidence-based treatment decisions in cancer. The founding and management team …See details»
PreComb Therapeutics AG - Hombrechtikon, Switzerland
Apr 28, 2021 About PreComb Therapeutics PreCombTherapeutics AG is a privately held Swiss biotechcompany focused on in vitro cancer diagnostic to improve cancer management. It's …See details»
Investors - PreComb - Functional cancer profiling
At PreComb, we are dedicated to rapidly deploy the 3DTwin® technology in the realm of personalized medicine, and setting a new standard for functional personalized oncology. Our …See details»
Board and Advisors - PreComb - Functional cancer profiling
The PreComb executive management is supported by a diverse team of high-profile strategic advisors from the biotech/pharma industry as well as from experts in clinical and preclinical …See details»
The first Responsome Company to predict Tumor Shrinkage
PreComb Therapeutics AG Garstligweg 8 8634 Hombrechtikon Switzerland Jens M. Kelm, CEO [email protected] Investors for Series A round Clinical and Pharma collaborations …See details»
PreComb Therapeutics AG - startup.ch
PreComb Therapeutics AG is a privately held Swiss biotech company developing proprietary technologies bringing functional precision medicine to clinical practice and enabling evidence …See details»
PreComb - Research - Overview, Competitors, and Employees
No credit card. No commitment. 5000+ G2 reviews 5000+ G2 reviews. PreCombSee details»
Press release: PreComb and mimiX announce co-operation to …
Feb 21, 2023 PreComb 's breakthrough 3DTwin® technology makes it possible to test drugs for tumor shrinkage directly on the tumor tissue of individual cancer patients. With the fully …See details»
Working at PreComb - PreComb - Functional cancer profiling
Working at PreComb means working at the forefront of a new technology to substantially improve the quality of life for cancer patients. Within a highly motivated, interdisciplinary, and creative …See details»
PreComb - YouTube
PreComb is developing the 3DTwin® platform for functional drug profiling in personalized oncology.See details»
News - PreComb - Functional cancer profiling
Nov 1, 2023 Euresearch, a Swiss non-profit organization funded by the State Secretariat for Education, ... PreComb Therapeutics AG is a swiss-based biotechnology company focusing …See details»
Collaborations - PreComb - Functional cancer profiling
PreComb collaborates with Prof. Dr. Olaf Witt and PD Dr. Ina Oehme to clinically validate the PreComb’s fully automated drug profiling solution (3DTwin™ technology) in pediatric patients. …See details»